早期持续预防性低温对重型颅脑创伤患者神经功能结局的影响:POLAR随机临床试验
POLAR-RCT为6国多中心随机试验,纳入511例重型颅脑创伤患者,比较早期预防性低温(33°C-35°C,至少72小时,颅内压升高时至多7天,随后缓慢复温)与常温管理(37°C,必要时体表降温)。主要终点为伤后6个月盲法评估的GOS-E 5-8分(良好神经功能结局或独立生活)。低温组48.8% vs 常温组49.1%达到主要终点(风险差0.4%,95%CI -9.4%至8.7%;RR 0.99,95%CI 0.82-1.19;P=0.94)。结论认为早期预防性低温未改善6个月神经功能结局,不支持用于重型颅脑创伤患者。
要点
- 重型颅脑创伤后6个月GOS-E 5-8分:低温组48.8% vs 常温组49.1%,风险差0.4%(95%CI -9.4%至8.7%),RR 0.99(95%CI 0.82-1.19),P=0.94。
- 低温组肺炎发生率55.0% vs 常温组51.3%,颅内出血增加发生率18.1% vs 15.4%。
- 低温在伤后中位1.8小时(IQR 1.0-2.7小时)内启动,复温中位耗时22.5小时(IQR 16-27小时)。
- 作者结论:早期预防性低温较常温未改善6个月神经功能结局,不支持对重型颅脑创伤患者使用早期预防性低温。
适用人群与场景
- 6国多中心招募的511例重型颅脑创伤患者,于院前和急诊科纳入,随机分为低温组266例和常温组245例。
- 500例提供持续知情同意并纳入分析(平均年龄34.5岁,SD 13.4;男性402例,80.2%),466例完成主要结局评估。
处置流程与药物剂量
- 预防性低温组:目标早期诱导低温33°C-35°C,至少持续72小时;若颅内压升高则延长至最多7天,随后缓慢复温。
- 常温组:目标体温37°C,必要时使用体表降温包裹。
- 两组体温管理均持续7天;其他所有治疗由主治医师决定。
研究设计与关键结果
- POLAR-RCT为6国多中心随机试验,2010年12月5日纳入首例、2017年11月10日纳入末例,最后随访日期2018年5月15日。
- 主要终点:伤后6个月盲法评估GOS-E 5-8分(量表范围1-8),低温组117例(48.8%)vs 常温组111例(49.1%),风险差0.4%(95%CI -9.4%至8.7%),低温相对危险度0.99(95%CI 0.82-1.19),P=0.94。
- 不良事件:肺炎发生率低温组55.0% vs 常温组51.3%;颅内出血增加发生率低温组18.1% vs 常温组15.4%。
证据类型、等级与局限
- 证据类型:多中心随机临床试验(POLAR-RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:重型颅脑创伤患者早期预防性低温较常温未改善6个月神经功能结局,这些发现不支持对重型颅脑创伤患者使用早期预防性低温。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: After severe traumatic brain injury, induction of prophylactic hypothermia has been suggested to be neuroprotective and improve long-term neurologic outcomes.
OBJECTIVE: To determine the effectiveness of early prophylactic hypothermia compared with normothermic management of patients after severe traumatic brain injury.
DESIGN, SETTING, AND PARTICIPANTS: The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury-Randomized Clinical Trial (POLAR-RCT) was a multicenter randomized trial in 6 countries that recruited 511 patients both out-of-hospital and in emergency departments after severe traumatic brain injury. The first patient was enrolled on December 5, 2010, and the last on November 10, 2017. The final date of follow-up was May 15, 2018.
INTERVENTIONS: There were 266 patients randomized to the prophylactic hypothermia group and 245 to normothermic management. Prophylactic hypothermia targeted the early induction of hypothermia (33°C-35°C) for at least 72 hours and up to 7 days if intracranial pressures were elevated, followed by gradual rewarming. Normothermia targeted 37°C, using surface-cooling wraps when required. Temperature was managed in both groups for 7 days. All other care was at the discretion of the treating physician.
MAIN OUTCOMES AND MEASURES: The primary outcome was favorable neurologic outcomes or independent living (Glasgow Outcome Scale-Extended score, 5-8 [scale range, 1-8]) obtained by blinded assessors 6 months after injury.
RESULTS: Among 511 patients who were randomized, 500 provided ongoing consent (mean age, 34.5 years [SD, 13.4]; 402 men [80.2%]) and 466 completed the primary outcome evaluation. Hypothermia was initiated rapidly after injury (median, 1.8 hours [IQR, 1.0-2.7 hours]) and rewarming occurred slowly (median, 22.5 hours [IQR, 16-27 hours]). Favorable outcomes (Glasgow Outcome Scale-Extended score, 5-8) at 6 months occurred in 117 patients (48.8%) in the hypothermia group and 111 (49.1%) in the normothermia group (risk difference, 0.4% [95% CI, -9.4% to 8.7%]; relative risk with hypothermia, 0.99 [95% CI, 0.82-1.19]; P = .94). In the hypothermia and normothermia groups, the rates of pneumonia were 55.0% vs 51.3%, respectively, and rates of increased intracranial bleeding were 18.1% vs 15.4%, respectively.
CONCLUSIONS AND RELEVANCE: Among patients with severe traumatic brain injury, early prophylactic hypothermia compared with normothermia did not improve neurologic outcomes at 6 months. These findings do not support the use of early prophylactic hypothermia for patients with severe traumatic brain injury.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00987688; Anzctr.org.au Identifier: ACTRN12609000764235.
参考来源
- Cooper DJ, Nichol AD, Bailey M, et al. Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial. JAMA. 2018. PMID: 30357266. doi:10.1001/jama.2018.17075
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。